Modafinil for the Treatment of Cocaine Dependence - 1

Completed · Phase 2

Conditions studied: Cocaine-Related Disorders

In brief

The purpose of this study is to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

Key facts

Study ID

NCT00100100

Run by

National Institute on Drug Abuse (NIDA)

People needed

210

Starts

2004-10-01

Expected to finish

2006-12-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant must have DSM-IV diagnosis of cocaine dependence as determined by SCID.
• Must be seeking treatment for cocaine dependence.
• Must be able to understand and provide written informed consent.

You may not qualify if…

• Please contact the study site for more information.

Where it is running

• Boston University Medical Center — Boston, Massachusetts, United States
• New York VA Medical Center — New York, New York, United States
• Cincinnati Addiction Research Center — Cincinnati, Ohio, United States
• Western Psychiatric Institute & Clinic — Pittsburgh, Pennsylvania, United States
• RHD Professional Plaza 4 — Dallas, Texas, United States
• UTHSCSA — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.